Sort   by:  
 Page size 
UnknownExploring drug cost and disease outcome in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs in Norway in 2010-2019 - a country with a national tender system for prescription of costly drugs.
Not available
S-EPMC8743354 | biostudies-literature
UnknownTherapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial.
Not available
S-EPMC11575345 | biostudies-literature
UnknownA DNA methylation-based algorithm for diagnosing rheumatoid arthritis.
Not available
S-EPMC12532955 | biostudies-literature
UnknownComparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial.
Not available
S-EPMC6269640 | biostudies-literature
UnknownPredicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study.
Not available
S-EPMC6242030 | biostudies-literature
UnknownFollow-Up of Patients With Axial Spondyloarthritis in Specialist Health Care With Remote Monitoring and Self-Monitoring Compared With Regular Face-to-Face Follow-Up Visits (the ReMonit Study): Protocol for a Randomized, Controlled Open-Label Noninferiority Trial.
Not available
S-EPMC10782285 | biostudies-literature
UnknownDevelopment of a feasible and responsive ultrasound inflammation score for rheumatoid arthritis through a data-driven approach.
Not available
S-EPMC5174791 | biostudies-literature
UnknownEffect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial.
Not available
S-EPMC10579188 | biostudies-literature
UnknownUltrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial.
Not available
S-EPMC4986519 | biostudies-literature
UnknownEffect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial.
Not available
S-EPMC8097499 | biostudies-literature
Sort   by:  
 Page size